Aqua Adducts Research Articles

Nickel complexes bearing substituted 2-(naphthylen-1-yl)iminopyridines as catalysts for the formation of highly branched unsaturated PE waxes

A set of six 2-iminopyridine-nickel(II) complexes, [2-{C(Me)=NAr}C5H4N]NiCl2 (Ar = 1-C10H7Ni1, 2-Me-1-C10H6Ni2, 2-(CHMePh)-1-C10H6Ni3, 4-(NNC6H5)-1-C10H6Ni4, 4-(NNC6H4-4-Me)-1-C10H6Ni5, 4-(NNC6H4-4-F)-1-C10H6Ni6), all N-functionalized with naphthalen-1-yl or its substituted alkyl or aryldiazenyl derivatives, have been readily synthesized from their corresponding free N,N-ligand, L1 – L6. On crystallization of Ni3, the chloride-bridged trimetallic species, [(L3)3Ni3Cl6(OH2)], was identified as an aqua adduct by single crystal X-ray diffraction. When activated with either MAO or MMAO, high catalytic activity for ethylene polymerization was achieved using Ni1–Ni6 (up to 10.1 × 106 g (PE) mol−1 h−1 for Ni3/MAO), affording low molecular weight polyethylene (Mw range: 0.81–3.50 kg mol−1) with low melting temperature and narrow dispersity. 13C NMR spectroscopic analyses of these polyethylenic waxes revealed the formation of branched macromolecules with branching densities up to 69 per 1000 carbons. Further analysis revealed these polymers to contain predominantly methyl branches (%Me range: 7.8–9.0), with lower levels of longer chain branching and some branch-on branch structure (%sec-Bu range: 0.07–0.12%). Moreover, their 1H and 13C NMR spectra showed various levels of unsaturated functionality in the form of terminal and internal olefins.

Fast Hydrolysis and Strongly Basic Water Adducts Lead to Potent Os(II) Half-Sandwich Anticancer Complexes.

Complexes of the formula [Os(η6-arene)(C,N-phenylpyridine)Z] (where Z is chlorido or a tethered oxygen) undergo very fast Os-Z hydrolysis (<5 min), and the high basicity of the coordinated water molecule of the aqua adducts (Os-OH2; pKa > 8) very much contrasts with previously reported Os-aqua adducts bearing NN- and NO-chelating ligands (pKa < 6). The Os-Cl bond is unreactive in pure DMSO, yet the complexes readily form DMSO adducts upon aquation when dimethyl sulfoxide is present. Such a peculiar aqueous behavior is directly related to the negatively charged CN ligand. Potent Os-CN compounds (but not their Os-NN analogues) are particularly reactive; they bind to cysteine in vitro and decrease the activity of thioredoxin reductase (TrxR) in living cancer cells. By revealing some interesting structure-activity relationship on Os-CN vs Os-NN complexes, we start uncovering the molecular rationale for the successful biological applications of osmium(II) half-sandwich compounds.

Effect of cysteine thiols on the catalytic and anticancer activity of Ru(II) sulfonyl-ethylenediamine complexes.

We have synthesized a series of novel substituted sulfonyl ethylenediamine (en) RuII arene complexes 1-8 of [(η6-arene)Ru(R1-SO2-EnBz)X], where the arene is benzene, HO(CH2)2O-phenyl or biphenyl (biph), X = Cl or I, and R1 is phenyl, 4-Me-phenyl, 4-NO2-phenyl or dansyl. The 'piano-stool' structure of complex 3, [(η6-biph)Ru(4-Me-phenyl-SO2-EnBz)I], was confirmed by X-ray crystallography. The values of their aqua adducts were determined to be high (9.1 to 9.7). Complexes 1-8 have antiproliferative activity against human A2780 ovarian, and A549 lung cancer cells with IC50 values ranging from 4.1 to >50 μM, although, remarkably, complex 7 [(η6-biph)Ru(phenyl-SO2-EnBz)Cl] was inactive towards A2780 cells, but as potent as the clinical drug cisplatin towards A549 cells. All these complexes also showed catalytic activity in transfer hydrogenation (TH) of NAD+ to NADH with sodium formate as hydride donor, with TOFs in the range of 2.5-9.7 h-1. The complexes reacted rapidly with the thiols glutathione (GSH) and N-acetyl-L-cysteine (NAC), forming dinuclear bridged complexes [(η6-biph)2Ru2(GS)3]2- or [(η6-biph)2Ru2(NAC-H)3]2-, with the liberation of the diamine ligand which was detected by LC-MS. In addition, the switching on of fluorescence for complex 8 in aqueous solution confirmed release of the chelated DsEnBz ligand in reactions with these thiols. Reactions with GSH hampered the catalytic TH of NAD+ to NADH due to the decomposition of the complexes. Co-administration to cells of complex 2 [(η6-biph)Ru(4-Me-phenyl-SO2-EnBz)Cl] with L-buthionine sulfoximine (L-BSO), an inhibitor of GSH synthesis, partially restored the anticancer activity towards A2780 ovarian cancer cells. Complex 2 caused a concentration-dependent G1 phase cell cycle arrest, and induced a significant level of reactive oxygen species (ROS) in A2780 human ovarian cancer cells. The amount of induced ROS decreased with increase in GSH concentration, perhaps due to the formation of the dinuclear Ru-SG complex.

Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.

Five complexes of formula [Ru(η6-C6H5CH2COOH)(XY)Cl]Cl/Na (XY = ethylenediamine (1), o-phenylenediamine (2), phenanthroline (3), and oxalato (4)) and [Ru(η6:κ1-C6H5CH2COO)(tmen)]Cl (tmen = N, N, N', N'-tetramethylethylenediamine, 5C) have been synthesized and fully characterized. Five new X-ray crystal structures ([Ru(η6-C6H5CH2COOH)(μ-Cl)Cl]2, 1, 3, 4, and 5C·PF6) have been determined, which are the first examples of ruthenium(II) structures with phenylacetic acid as arene ligand. Furthermore, 5C·PF6 is the first example of a five-membered tether ring with a Ru(η6:κ1-arene:O) bond. The tether ring in these complexes opens in acidic pH (<5) and closes reversibly in aqueous solution. The chlorido open-form undergoes aquation, and the aqua adduct can be observed (prior to ring closure) by NMR. The speciation has an attractive complexity in the pH range 0-12, showing interconversion of the three species (chlorido, aqua, and closed tether), dependent on the proton concentration and the nature of the XY chelating ligand. The closed tether version of 3, complex 3C, with σ-donor/π-acceptor phenanthroline as chelating ligand, opens up more readily (pH 4), while the tether ring in complex 5C hardly opens even at pH as low as 1. We have determined the p Ka of the pendant carboxylic group and that of the aqua adduct (ca. 3 and ca. 7, respectively), which can be finely tuned by the appropriate choice of XY. Complexes 1 and 2, which predominate in their inactive (closed-tether) form in intracellular conditions, show some cytotoxic activity (IC50 130 and 117 μM, respectively) in A2780 ovarian cancer cells. Complex 1 catalyzes the reduction through transfer hydrogenation of pyruvate to lactate and NAD+ to NADH in the presence of formate as H-source. Co-incubation with sodium formate decreases the IC50 value of 1 in A2780 cancer cells significantly.

Upconverting Nanoparticles Prompt Remote Near-Infrared Photoactivation of Ru(II)-Arene Complexes.

The synthesis and full characterisation (including X-ray diffraction studies and DFT calculations) of two new piano-stool Ru(II) -arene complexes, namely [(η(6) -p-cym)Ru(bpy)(m-CCH-Py)][(PF)6]2 (1) and [(η(6) -p-cym)Ru(bpm)(m-CCH-Py)][(PF)6]2 (2; p-cym=p-cymene, bpy=2,2'-bipyridine, bpm=2,2'-bipyrimidine, and m-CCH-Py=3-ethynylpyridine), is described and discussed. The reaction of the m-CCH-Py ligand of 1 and 2 with diethyl-3-azidopropyl phosphonate by Cu-catalysed click chemistry affords [(η(6) -p-cym)Ru(bpy)(P-Trz-Py)][(PF)6]2 (3) and [(η(6) -p-cym)Ru(bpm)(P-Trz-Py)][(PF)6]2 (4; P-Trz-Py=[3-(1-pyridin-3-yl-[1,2,3]triazol-4-yl)-propyl]phosphonic acid diethyl ester). Upon light excitation at λ=395 nm, complexes 1-4 photodissociate the monodentate pyridyl ligand and form the aqua adduct ions [(η(6) -p-cym)Ru(bpy)(H2O)](2+) and [(η(6) -p-cym)Ru(bpm)(H2O)](2+). Thulium -doped upconverting nanoparticles (UCNPs) are functionalised with 4, thus exploiting their surface affinity for the phosphonate group in the complex. The so-obtained nanosystem UCNP@4 undergoes near-infrared (NIR) photoactivation at λ=980 nm, thus producing the corresponding reactive aqua species that binds the DNA-model base guanosine 5'-monophosphate.

Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activity.

For the first time, a series of 25 pseudo-octahedral pyridylphosphinate metal complexes (Ru, Os, Rh, Ir) has been synthesised and assessed in biological systems. Each metal complex incorporates a pyridylphosphinate ligand, a monodentate halide and a capping η(6)-bound aromatic ligand. Solid- and solution-state analyses of two complexes reveal a structural preference for one of a possible two diastereomers. The metal chlorides hydrolyse rapidly in D2O to form a 1 : 1 equilibrium ratio between the aqua and chloride adducts. The pKa of the aqua adduct depends upon the pyridyl substituent and the metal but has little dependence upon the phosphinate R' group. Toxicity was measured in vitro against non-small cell lung carcinoma H460 cells, with the most potent complexes reporting IC50 values around 50 μM. Binding studies with selected amino acids and nucleobases provide a rationale for the variation in toxicity observed within the series. Finally, an investigation into the ability of the chelating amino acid l-His to displace the phosphinate O-metal bond shows the potential for phosphinate complexes to act as prodrugs that can be activated in the intracellular environment.

Half-sandwich rhodium(III) transfer hydrogenation catalysts: Reduction of NAD+ and pyruvate, and antiproliferative activity

Organometallic complexes have the potential to behave as catalytic drugs. We investigate here Rh(III) complexes of general formula [(Cpx)Rh(N,N′)(Cl)], where N,N′ is ethylenediamine (en), 2,2′-bipyridine (bpy), 1,10-phenanthroline (phen) or N-(2-aminoethyl)-4-(trifluoromethyl)benzenesulfonamide (TfEn), and Cpx is pentamethylcyclopentadienyl (Cp*), 1-phenyl-2,3,4,5-tetramethylcyclopentadienyl (CpxPh) or 1-biphenyl-2,3,4,5-tetramethyl cyclopentadienyl (CpxPhPh). These complexes can reduce NAD+ to NADH using formate as a hydride source under biologically-relevant conditions. The catalytic activity decreased in the order of N,N-chelated ligand bpy > phen > en with Cp* as the η5-donor. The en complexes (1–3) became more active with extension to the CpX ring, whereas the activity of the phen (7–9) and bpy (4–6) compounds decreased. [Cp*Rh(bpy)Cl]+ (4) showed the highest catalytic activity, with a TOF of 37.4±2h−1. Fast hydrolysis of the chlorido complexes 1–10 was observed by 1H NMR (<10min at 310K). The pKa* values for the aqua adducts were determined to be ca. 8–10. Complexes 1–9 also catalysed the reduction of pyruvate to lactate using formate as the hydride donor. The efficiency of the transfer hydrogenation reactions was highly dependent on the nature of the chelating ligand and the Cpx ring. Competition reactions between NAD+ and pyruvate for reduction by formate catalysed by 4 showed a preference for reduction of NAD+. The antiproliferative activity of complex 3 towards A2780 human ovarian cancer cells increased by up to 50% when administered in combination with non-toxic doses of formate, suggesting that transfer hydrogenation can induce reductive stress in cancer cells.

Bis(iminopyridyl)phthalazine as a sterically hindered compartmental ligand for an M2 (M = Co, Ni, Fe, Zn) centre; Applications in ethylene oligomerisation

The new bis(iminopyridyl)phthalazine ligand, 1,4-{(2,6-i-Pr2C6H3)NCMe)C5H3N}2C8H4N2 (L), has been prepared in good yield using a combination of palladium-mediated cross coupling and condensation strategies. Reaction of L with three equivalents of CoX2 (X=Cl, Br) in n-BuOH at elevated temperature generates, on crystallisation from bench acetonitrile, the paramagnetic tetrahalocobaltate salts [(L)Co2X(μ-X)(NCMe)m(OH2)n](CoX4) (X=Cl, m=2, n=1 1a; X=Br, m=2, n=0 1b) as acetonitrile or mixed acetonitrile/aqua adducts; a similar product is obtained from the reaction of FeCl2 with L and has been tentatively assigned as [(L)Fe2Cl(μ-Cl)(OH2)3](FeCl4) (2). By contrast, reaction of L with NiX2(DME) (X=Cl, Br; DME=1,2-dimethoxyethane), under similar reaction conditions, affords the halide salts [(L)Ni2X2(μ-X)(OH2)2](X) (X=Cl 3a, X=Br 3b) as aqua adducts. Structural determinations on 1 and 3 reveal L to adopt a bis(tridentate) bonding mode allowing the halide-bridged metal centres to assemble in close proximity (M⋯M range: 3.437–3.596Å). Unexpectedly, on reaction of L with ZnCl2, the neutral bimetallic [(L)Zn2Cl4] (4b) complex is formed in which the ZnCl2 units fill inequivalent binding sites within L (viz. the Nphth,Npy,Nim and Npy,Nim pockets). Complex 4b could also be obtained by the sequential addition of ZnCl2 to L to form firstly monometallic [(L)ZnCl2] (4a) and then on further ZnCl2 addition 4b; the fluxional behaviour of diamagnetic 4a and 4b is also reported. On activation with excess methylaluminoxane (MAO), 1–3 display modest activities for ethylene oligomerisation forming low molecular weight waxes with methyl-branched products predominating for the nickel systems (3). On the other hand, the iron catalyst (2) gives exclusively α-olefins while the cobalt systems (1) are much less selective affording equal mixtures of α-olefins and internal olefins along with lower levels of vinylidenes and tri-substituted alkenes. Single crystal X-ray structures are reported for L, 1a, 1b, 3a, 3b and 4.

Optimizing the electronic properties of photoactive anticancer oxypyridine-bridged dirhodium(II,II) complexes.

A series of partial paddlewheel dirhodium compounds of general formula cis-[Rh2(xhp)2(CH3CN)n][BF4]2 (n = 5 or 6) were synthesized {xhp = 6-R-2-oxypyridine ligands, R = -CH3 (mhp), -F (fhp), -Cl (chp)}. X-ray crystallographic studies indicate the aforementioned compounds contain two cis-oriented bridging xhp ligands, with the remaining sites being coordinated by CH3CN ligands. The lability of the equatorial (eq) CH3CN groups in these complexes in solution is in the order -CH3 > -Cl > -F, in accord with the more electron rich bridging ligands exerting a stronger trans effect. In the case of cis-[Rh2(chp)2(CH3CN)6][BF4]2 (5), light irradiation enhances the production of the aqua adducts in which eq CH3CN is replaced by H2O molecules, whereas the formation of the aqua species for cis-[Rh2(fhp)2(CH3CN)6][BF4]2 (7) is only slightly increased by irradiation. The potential of both compounds to act as photochemotherapy agents was evaluated. A 16.4-fold increase in cytotoxicity against the HeLa cell line was observed for 5 upon 30 min irradiation (λ > 400 nm), in contrast to the nontoxic compound 7, which is in accord with the results from the photochemistry. Furthermore, the cell death mechanism induced by 5 was determined to be apoptosis. These results clearly demonstrate the importance of tuning the ligand field around the dimetal center to maximize the photoreactivity and achieve the best photodynamic action.

C–O Bond Activation by a Tantalum‐Bonded Pincer Ligand – Ligand Modification Effects on the Selectivity of C–H Bond Cleavage Processes

AbstractThe tantalum complexes [TaCp*Me{(OCH2)(OCHCO2)py‐κ4‐N,O,O,O}]2 (2, Cp* = η5‐C5Me5, py = pyridyl) and [TaCp*Me{(OCH2)(OCHCONAr)py‐κ4‐N,O,O,O}]2 (3, Ar = p‐tolyl) have been synthesized by the reactions of [TaCp*Me{(OCH2)(OCH)py‐κ3‐N,O,O}] (1) with CO2 and p‐tolyl isocyanate, respectively. The reaction of 3 with an excess of water renders the corresponding tantalum hydroxide [TaCp*Me(OH){(OCH2)(OCHCONHAr)py‐κ3‐N,O,O}] (4). Compound 1 reacts with pyridyl triflate (pyOTf) to afford the new pyridyl‐functionalized pincer derivative [TaCp*Me{(OCH2)(OCHpy)py‐κ3‐N,O,O}(OTf)] (5). Compound 5 reacts with water to yield the aqua adduct [TaCp*Me(OH2){(OCH2)(OCHpy)py‐κ3‐N,O,O}]OTf (6). The reaction of 5 with LiN(SiMe3)2 gives rise to the new tantalum compound [TaCp*Me{(OCH2)(OCpy)py‐κ3‐N,O,O}] (7). Complex 7 reacts with pyOTf to give the dipyridyl‐functionalized pincer derivative [TaCp*Me{(OCH2)(OCpy2)py‐κ3‐N,O,O}(OTf)] (8). The molecular structures of complexes 2, 4 and 6 have been established by single‐crystal X‐ray diffraction studies.

Role of the Metal, Ligand, and Alkyl/Aryl Group in the Hydrolysis Reactions of Group 10 Organometallic Cations [(L)M(R)]+

The reactions of water with the coordinatively unsaturated group 10 organometallic cations [(L)M(R)]+ (4; where L = 1,10-phenanthroline (phen), neocuproine (neo); M = nickel, palladium, platinum; R = CH3, C6H5, CH2C6H5), formed via decarboxylation of the carboxylate complexes [(L)M(O2CR)]+, were examined in the gas phase using a combination of multistage mass spectrometry experiments and DFT calculations at the M06/SDD6-31+G(d) level of theory. Two main types of primary product ions were observed: the aqua adduct [(L)M(R)(H2O)]+ (5) and the hydroxide [(L)M(OH)]+ (7), formed via a hydrolysis reaction. A secondary product ion, arising from formation of the adduct [(L)M(OH)(H2O)]+, was also observed when L = phen, R = CH3, and M = Pt. The rates of reaction of 4 and the product branching ratios for 5 and 7 were dependent upon the nature of M, L, and R. When L = phen and R = CH3, the hydroxide 7 dominates for Ni, with the adduct 5 as the major product for both Pd and Pt. For R = C6H5 the rate of the reaction i...

Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity

The synthesis and characterization of complexes [(η(6)-arene)Ru(N,N')X][PF(6)], where arene is para-cymene (p-cym), biphenyl (bip), ethyl benzoate (etb), hexamethylbenzene (hmb), indane (ind) or 1,2,3,4-tetrahydronaphthalene (thn), N,N' is 2,2'-bipyrimidine (bpm) and X is Cl, Br or I, are reported, including the X-ray crystal structures of [(η(6)-p-cym)Ru(bpm)I][PF(6)], [(η(6)-bip)Ru(bpm)Cl][PF(6)], [(η(6)-bip)Ru(bpm)I][PF(6)] and [(η(6)-etb)Ru(bpm)Cl][PF(6)]. Complexes in which N,N' is 1,10-phenanthroline (phen), 1,10-phenanthroline-5,6-dione or 4,7-diphenyl-1,10-phenanthroline (bathophen) were studied for comparison. The Ru(II) arene complexes undergo ligand-exchange reactions in aqueous solution at 310 K; their half-lives for hydrolysis range from 14 to 715 min. Density functional theory calculations on [(η(6)-p-cym)Ru(bpm)Cl][PF(6)], [(η(6)-p-cym)Ru(bpm)Br][PF(6)], [(η(6)-p-cym)Ru(bpm)I][PF(6)], [(η(6)-bip)Ru(bpm)Cl][PF(6)], [(η(6)-bip)Ru(bpm)Br][PF(6)] and [(η(6)-bip)Ru(bpm)I][PF(6)] suggest that aquation occurs via an associative pathway and that the reaction is thermodynamically favourable when the leaving ligand is I > Br ≈ Cl. pK (a)* values for the aqua adducts of the complexes range from 6.9 to 7.32. A binding preference for 9-ethylguanine (9-EtG) compared with 9-ethyladenine (9-EtA) was observed for [(η(6)-p-cym)Ru(bpm)Cl][PF(6)], [(η(6)-hmb)Ru(bpm)Cl](+), [(η(6)-ind)Ru(bpm)Cl](+), [(η(6)-thn)Ru(bpm)Cl](+), [(η(6)-p-cym)Ru(phen)Cl](+) and [(η(6)-p-cym)Ru(bathophen)Cl](+) in aqueous solution at 310 K. The X-ray crystal structure of the guanine complex [(η(6)-p-cym)Ru(bpm)(9-EtG-N7)][PF(6)](2) shows multiple hydrogen bonding. Density functional theory calculations show that the 9-EtG adducts of all complexes are thermodynamically preferred compared with those of 9-EtA. However, the bmp complexes are inactive towards A2780 human ovarian cancer cells. Calf thymus DNA interactions for [(η(6)-p-cym)Ru(bpm)Cl][PF(6)] and [(η(6)-p-cym)Ru(phen)Cl][PF(6)] consist of weak coordinative, intercalative and monofunctional coordination. Binding to biomolecules such as glutathione may play a role in deactivating the bpm complexes.

Paramagnetic 19F Chemical Shift Probes that Respond Selectively to Calcium or Citrate Levels and Signal Ester Hydrolysis

Paramagnetic magnetic resonance chemical shift probes containing a proximal CF(3) group have been characterised. Different systems have been created that report reversible changes in calcium ion concentrations in the millimolar regime, signal the presence of citrate selectively in competitive aqueous media and allow the monitoring of remote ester/amide hydrolysis in relayed, irreversible transformations. Chemical shift non-equivalence is amplified by the presence of the proximate lanthanide ion, with a mean separation between the CF(3) group and the metal ion of 6.4 Å found for a thulium complex, in an X-ray structure of the metal complex aqua adduct. The enhanced rate of longitudinal relaxation of the (19)F nucleus allows faster data acquisition.

Photodissociation of a ruthenium(II) arene complex and its subsequent interactions with biomolecules: a density functional theory study

The piano-stool Ru(II) arene complex [(η⁶-benz)Ru(bpm)(py)]²⁺ (benz = benzene, bpm = 2,2'-bipyrimidine, and py = pyridine), which is conventionally nonlabile (on a timescale and under conditions relevant for biological reactivity), can be activated by visible light to selectively photodissociate the monodentate ligand (py). In the present study, the aquation and binding of the photocontrolled ruthenium(II) arene complex [(η⁶-benz)Ru(bpm)(py)]²⁺ to various biomolecules are studied by density functional theory (DFT) and time-dependent DFT (TDDFT). Potential energy curves (PECs) calculated for the Ru-N (py) bonds in [(η⁶-benz)Ru(bpm)(py)]²⁺ in the singlet and triplet state give useful insights into the photodissociation mechanism of py. The binding energies of the various biomolecules are calculated, which allows the order of binding affinities among the considered nuleic-acid- or protein-binding sites to be discerned. The kinetics for the replacement of water in the aqua complex with biomolecules is also considered, and the results demonstrate that guanine is superior to other biomolecules in terms of coordinating with the Ru(II) aqua adduct, which is in reasonable agreement with experimental observations.

Aquation and dimerization of osmium(ii) anticancer complexes: a density functional theory study

In this paper, the hydrolytic and aqueous solution chemistry of two half-sandwich OsII arene complexes [(η6-p-cym)Os(pic)Cl] (1) and [(η6-p-cym)Os(mal)Cl] (2) (pic = 2-picolinic acid and mal = maltolate) have been investigated using density functional theory (DFT). For aquation (substitution of chloride by H2O) of the complexes, three attacking models were explored, including two forms of side attack (A and B) and back attack C. Side attack A required the lowest free energy of activation of the three, both in the gas phase and in aqueous solution, suggesting that it best describes the hydrolysis of the complexes. Both the activation and reaction energies indicated faster aquation for 2 than 1, which was in accordance with previous experimental observations. With the side attack model of the complexes, it was found that the conformations of complexes had little effect on the aquation process. Moreover, mechanistic pathways have been obtained for the dimerization of aqua adducts. As for 1a, the ligand departure was the rate-determining step with an activation free energy of 26.1 kcal mol−1, while for 2a, the first step of ring opening and protonation is rate-determining with a free energy of activation of 24.8 kcal mol−1, suggesting that 1a was kinetically more stable toward dimerization. There were three factors presented to explain the stability of 1a: differences in HOMO/LUMO densities, the large activation energy of 1a, and stabilization of Os-pic bonding. This study assists in understanding the aqueous solution chemistry of the anticancer complexes and in the design of novel anticancer drugs.

Acid–base equilibria of the aqua adducts of Ru(II) arene complexes with functionalised pyridines

Acid–base equilibria of the aqua adducts of Ru(II) arene complexes, general formulae [(η6-p-cymene)Ru (L1−3)Cl2] where L1 = 3-acetylpyridine (1), L2 = 4-acetylpyridine (2) and L3 = 2-amino-5-chloropyridine (3), then [(η6-p-cymene)Ru(HL4)Cl2] with HL4 = isonicotinic acid (4); [(η6-p-cymene)Ru(HL5−8)Cl] where H2L5 = 2,3-pyridine dicarboxylic acid (5), H2L6 = 2,4-pyridine dicarboxylic acid (6), H2L7 = 2,5-pyridine dicarboxylic acid (7) and H2L8 = 2,6-pyridine dicarboxylic acid (8) have been studied. pKa values were determined by potentiometry at 25 °C and constant ionic strength of 0.1 M NaNO3. The assumed equilibria were confirmed by UV and 1H-NMR spectroscopy.

A cationic rhodium(I) N-heterocyclic carbene complex isolated as an aqua adduct

The title complex, aqua­[1,3-bis­(2,6-diiso­propyl­phen­yl)imid­az­ol-2-yl­idene](η4-cyclo­octa-1,5-diene)rhodium(I) tetra­fluor­ido­borate, [Rh(C8H12)(C27H36N2)(H2O)]BF4, exihibits a square-planar geometry around the Rh(I) atom, formed by a bidentate cyclo­octa-1,5-diene (cod) ligand, an N-heterocylcic carbene and an aqua ligand. The complex is cationic and a BF4 − anion balances the charge. The structure exists as a hydrogen-bonded dimer in the solid state, formed via inter­actions between the aqua ligand H atoms and the BF4 − F atoms.

Organometallic Osmium(II) Arene Anticancer Complexes Containing Picolinate Derivatives

Chlorido osmium(II) arene [(eta(6)-biphenyl)Os(II)(X-pico)Cl] complexes containing X = Br (1), OH (2), and Me (3) as ortho, or X = Cl (4), CO(2)H (5), and Me (6) as para substituents on the picolinate (pico) ring have been synthesized and characterized. The X-ray crystal structures of 1 and 6 show typical "piano-stool" geometry with intermolecular pi-pi stacking of the biphenyl outer rings of 6. At 288 K the hydrolysis rates follow the order 2 >> 6 > 4 > 3 > 5 >> 1 with half-lives ranging from minutes to 4.4 h illustrating the influence of both electronic and steric effects of the substituents. The pK(a) values of the aqua adducts 3A, 4A, 5A, and 6A were all in the range of 6.3-6.6. The para-substituted pico complexes 4-6 readily formed adducts with both 9-ethyl guanine (9EtG) and 9-ethyl adenine (9EtA), but these were less favored for the ortho-substituted complexes 1 and 3 showing little reaction with 9EtG and 9EtA, respectively. Density-functional theory calculations confirmed the observed preferences for nucleobase binding for complex 1. In cytotoxicity assays with A2780, cisplatin-resistant A2780cis human ovarian, A549 human lung, and HCT116 colon cancer cells, only complexes 4 (p-Cl) and 6 (p-Me) exhibited significant activity (IC(50) values < 25 microM). Both of these complexes were as active as cisplatin in A2780 (ovarian) and HCT116 (colon) cell lines, and even overcome cisplatin resistance in the A2780cis (ovarian) cell line. The inactivity of 5 is attributed to the negative charge on its para carboxylate substituent. These data illustrate how the chemical reactivity and cancer cell cytotoxicity of osmium arene complexes can be controlled and "fine-tuned" by the use of steric and electronic effects of substituents on a chelating ligand to give osmium(II) arene complexes which are as active as cisplatin but have a different mechanism of action.

Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands

The synthesis and X-ray structures of a half-sandwich RuIIp-cymene β-diketonato complex as chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts are reported. Structural features which contribute to stabilisation of adducts through non-covalent, weak interactions are discussed. The X-ray crystal structure of the cytotoxic complex [(η6-p-cym)Ru(Ph2acac)Cl] (1), where Ph2acac=1,3-diphenyl-1,3-propanedionate and p-cym=para-cymene, shows that the phenyl rings of the acac-type ligand form a hydrophobic face, conferring lipophilic character on the complex. The structure of the aqua adduct [(η6-p-cym)Ru(Ph2acac)H2O]CF3SO3·H2O·Et2O (4·H2O·Et2O), a possible activated species, possesses a comparatively short Ru–OH2 bond. In the structure of [(η6-p-cym)Ru(Ph2acac)9EtG-N7]CF3SO3·2tol (5·2tol), where tol=toluene and 9EtG=9-ethylguanine, a comparatively long Ru–N7 bond is observed in addition to weak G CH8⋯O (Ph2acac) H-bonds. The crystal structure of [(η6-p-cym)Ru(acac)9EtA-N7]PF6 (6), where acac=acetylacetonate and 9EtA=9-ethyladenine, a rare example of a ruthenium complex containing monodentate adenine, shows a strong H-bonding interaction between N6H⋯O(acac), which may contribute to the selectivity of {(η6-p-cym)Ru(acac)}+ towards adenine bases.

Chloro Half-Sandwich Osmium(II) Complexes: Influence of Chelated N,N-Ligands on Hydrolysis, Guanine Binding, and Cytotoxicity

Relatively little is known about the kinetics or the pharmacological potential of organometallic complexes of osmium compared to its lighter congeners, iron and ruthenium. We report the synthesis of seven new complexes, [(eta6-arene)Os(NN)Cl]+, containing different bidentate nitrogen (N,N) chelators, and a dichlorido complex, [(eta6-arene)Os(N)Cl2]. The X-ray crystal structures of seven complexes are reported: [(eta6-bip)Os(en)Cl]PF6 (1PF6), [(eta6-THA)Os(en)Cl]BF4 (2BF4), [(eta6-p-cym)Os(phen)Cl]PF6 (5PF6), [(eta6-bip)Os(dppz)Cl]PF6 (6PF6), [(eta6-bip)Os(azpy-NMe2)Cl]PF6 (7PF6), [(eta6-p-cym)Os(azpy-NMe2)Cl]PF6 (8PF6), and [(eta6-bip)Os(NCCH3-N)Cl2] (9), where THA = tetrahydroanthracene, en = ethylenediamine, p-cym = p-cymene, phen = phenanthroline, bip = biphenyl, dppz = [3,2-a: 2',3'-c]phenazine and azpy-NMe2 = 4-(2-pyridylazo)-N,N-dimethylaniline. The chelating ligand was found to play a crucial role in enhancing aqueous stability. The rates of hydrolysis at acidic pH* decreased when the primary amine N-donors (NN = en, t1/2 = 0.6 h at 318 K) are replaced with pi-accepting pyridine groups (e.g., NN = phen, t1/2 = 9.5 h at 318 K). The OsII complexes hydrolyze up to 100 times more slowly than their RuII analogues. The pK*a of the aqua adducts decreased with a similar trend (pK*a = 6.3 and 5.8 for en and phen adducts, respectively). [(eta6-bip)Os(en)Cl]PF6/BF4 (1PF6/BF4) and [(eta6-THA)Os(en)Cl]BF4 (2BF4) were cytotoxic toward both the human A549 lung and A2780 ovarian cancer cell lines, with IC50 values of 6-10 microM, comparable to the anticancer drug carboplatin. 1BF4 binds to both the N7 and phosphate of 5'-GMP (ratio of 2:1). The formation constant for the 9-ethylguanine (9EtG) adduct [(eta6-bip)M(en)(9EtG)]2+ was lower for OsII (log K = 3.13) than RuII (log K = 4.78), although the OsII adduct showed some kinetic stability. DNA intercalation of the dppz ligand in 6PF6 may play a role in its cytotoxicity. This work demonstrates that the nature of the chelating ligand can play a crucial role in tuning the chemical and biological properties of [(eta6-arene)Os(NN)Cl]+ complexes.